Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma.
J Immunother Cancer
; 8(2)2020 08.
Article
in En
| MEDLINE
| ID: mdl-32847986
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immunohistochemistry
/
Carcinoma, Hepatocellular
/
ADP-ribosyl Cyclase 1
/
Tumor Microenvironment
/
B7-H1 Antigen
/
Immunotherapy
/
Liver Neoplasms
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
Language:
En
Journal:
J Immunother Cancer
Year:
2020
Document type:
Article
Affiliation country:
Singapur
Country of publication:
Reino Unido